Evidence map

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2020

Effect of Anagliptin versus Sitagliptin on Inflammatory Markers: Sub-Analysis from the REASON Trial.

Hiroki Teragawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2020
2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33364803